DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10003LMP | DABRAFENIB dabrafenib 75 mg capsule, 120 (PI, CMI) |
1 | 120 | 5 | $7158.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11820DMP | DABRAFENIB dabrafenib 50 mg capsule, 120 (PI, CMI) |
1 | 120 | 3 | $4799.35 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11823GMP | DABRAFENIB dabrafenib 75 mg capsule, 120 (PI, CMI) |
1 | 120 | 3 | $7158.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14752KMP | DABRAFENIB dabrafenib 10 mg dispersible tablet, 2 x 210 (PI, CMI) |
2 | 840 | 1 | $6691.82 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14753LMP | DABRAFENIB dabrafenib 10 mg dispersible tablet, 2 x 210 (PI, CMI) |
2 | 840 | 3 | $6691.82 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14754MMP | DABRAFENIB dabrafenib 75 mg capsule, 120 (PI, CMI) |
1 | 120 | 3 | $7158.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14755NMP | DABRAFENIB dabrafenib 50 mg capsule, 120 (PI, CMI) |
2 | 240 | 3 | $9489.92 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14757QMP | DABRAFENIB dabrafenib 75 mg capsule, 120 (PI, CMI) |
1 | 120 | 3 | $7158.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14760WMP | DABRAFENIB dabrafenib 50 mg capsule, 120 (PI, CMI) |
2 | 240 | 1 | $9489.92 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14766EMP | DABRAFENIB dabrafenib 75 mg capsule, 120 (PI, CMI) |
1 | 120 | 1 | $7158.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14773MMP | DABRAFENIB dabrafenib 10 mg dispersible tablet, 2 x 210 (PI, CMI) |
2 | 840 | 3 | $6691.82 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14778TMP | DABRAFENIB dabrafenib 50 mg capsule, 120 (PI, CMI) |
2 | 240 | 3 | $9489.92 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 15055JMP | DABRAFENIB dabrafenib 75 mg capsule, 120 (PI, CMI) |
1 | 120 | 5 | $7158.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 15056KMP | DABRAFENIB dabrafenib 50 mg capsule, 120 (PI, CMI) |
1 | 120 | 5 | $4799.35 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 2846TMP | DABRAFENIB dabrafenib 75 mg capsule, 120 (PI, CMI) |
1 | 120 | 3 | $7158.16 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 2954LMP | DABRAFENIB dabrafenib 50 mg capsule, 120 (PI, CMI) |
1 | 120 | 5 | $4799.35 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
DABRAFENIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 2963YMP | DABRAFENIB dabrafenib 50 mg capsule, 120 (PI, CMI) |
1 | 120 | 3 | $4799.35 | $31.60 | $31.60 |
| Available brands | |||||||
| Tafinlar |
- Legend
- MPMedical Practitioner




